Mr. Speaker, my question has to do with health.
I strongly believe stem cell therapies represent a tremendous opportunity to improve and/or alleviate human suffering, reduce the economic burden of health care costs for Canadians and create new long-term jobs in the delivery of regenerative medicine. It is key to ensure that Canadians are the first to benefit from this Canadian discovery and have access to these new therapies in a safe, fair and timely manner.
Does the hon. member think that the federal government should increase financial support for stem cell research from basic science to early phase clinical trials to globally competitive levels?